Association of Movement Disorder Advanced Practice Providers

The DIMD Course, or Diamond Course, is a self-paced, free-to-use learning resource, developed by Neurocrine Biosciences, that explores various clinical aspects of DIMDs, including acute dystonia, akathisia, drug-induced parkinsonism, and tardive dyskinesia. Comprised of four online modules, this comprehensive course is designed to equip healthcare practitioners with the knowledge and tools necessary to better understand and address the needs of their patients. Sign up today & enhance your knowledge! https://lnkd.in/gm2dr9a5

APPs! If you will be in attending MDS in Philadelphia, or live in the region, we invite you to connect with us at AMDAPP's Cocktail Reception. We can't wait to see you! Reserve your spot below.

Check out our Anniversary Edition Newsletter!

🌟 APPs! Do you know a deserving NP? Let's celebrate them! 🌟

🧠 Exciting News for Healthcare Professionals! 🧠 Join us at the NeuroCME event in Chicago! This is a fantastic opportunity to deepen your knowledge, and connect with experts in the field. 📅 Date: August 24, 2024 📍 Location: Chicago Marriott Oak Brook (1401 West 22nd Street, Oak Brook, Illinois, 60523) 💰 Cost: Free 🎓 Credits: 6 CME Credits Don’t miss out on this valuable experience. Secure your spot now and enhance your expertise in neurology! For more details and registration, visit www.neurocme.org. 👉 Please share this post with colleagues and friends who might be interested! #NeuroCME #Neurology #CME #MedicalEducation #ChicagoEvent #FreeCME

Pseudobulbar affect is a disorder of emotional expression that affects more than a third of patients with brain injury or neurodegenerative diseases. Despite its frequency, pseudobulbar affect is underdiagnosed. Learn more here ▶ https://bit.ly/3WMwz5Y

Join us for Journal Club August 13th 6:00-7:00p EDT for discussion on the newly FDA approved (8/7) medication for the treatment of Parkinson's Disease, CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules! This Journal Club is an opportunity to dig in to the data and better understand a treatment anticipated to be a game changer! Come learn from expert faculty: Stuart Isaacson, MD, FAAN and Randi Loomis, ARNP from the Parkinson’s Disease and Movement Disorders Center in Boca Raton, FL. Together they have experience managing patients enrolled in the clinical trials with IPX203! Don't miss out! Members can register today at www.amdapp.org , under events. Not a member?? Join us at www.amdapp.org

It's a great day for the PD community! We are so proud of our partners! Congrats on all your efforts, Amneal Pharmaceuticals!

We are thrilled to announce that the esteemed Dr. Jean Hubble has joined us as our new Board Chair. With Dr. Hubble's exceptional leadership and vast experience, we are confident that we will continue to advance our mission and achieve new milestones in the field of movement disorders. Dr. Hubble's dedication and vision will undoubtedly inspire our team and enhance our efforts to make a meaningful impact.

This weekend was extraordinary for Association of Movement Disorder Advanced Practice Providers as we completed a major milestone in the development of the certification for APPs in movement disorders. We have been working diligently since January 2023 and are on track to launch the certification in January 2025. With the dedication of over 50 APP and MDS volunteers, the dream of showcasing and demonstrating the expertise of APPs in the management of movement disorders is becoming a reality. As the burden and crisis of access to specialized care intensify each year, we hope this certification will create new opportunities for identifying and providing quality care. A huge thank you to Professional Testing Corporation (PTC) for your guidance and support on this important initiative. Thank you to all of the many volunteers and to Sherrie Gould Maria Cristina Ospina MD, MBA Amanda Hare, DNP Jill Giordano Farmer & Maria Schmidt, NP for the time commitment this weekend. 💫 #MovementDisorders #APPs #Certification #AMDAPP